References
- Lichtlen PR, Nikutta P, Jost S, et al. Anatomical progression of coronary artery disease in humans as seen by prospective, repeated, quantitated coronary angiography: relation to clinical events and risk factors. The INTACT Study Group. Circuladon 1992;86(3):828–38
- Vogel RA. Comparative clinical consequences of aggressive lipid management, coronary angioplasty and bypass surgery in coronary artery disease. (Editorial) Am J Cardiol 1992; 69(14): 1229–33
- Ornish D, Brown SE, Scherwitz LW, et al. Can lifestyle changes reverse coronary heart disease? The Lifestyle Heart Trial. Lancet 1990; 336(8708):129–33
- Watts GF, Lewis B, Brunt JN, et al. Effects on coronary artery disease of lipid-lowering diet, or diet plus cholestyramine, in the St Thomas' Atherosclerosis Regression Study (STARS). Lancet 1992;339(8793):563–9
- Kane JP, Malloy MJ, Ports TA, et al. Regression of coronary atherosclerosis during treatment of familial hypercholesterolemia with combined drug regimens. JAMA 1990;264(23): 3007–12
- Brown G, Albers JJ, Fisher LD, et al. Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B. N Engl J Med 1990;323(19): 1289–98
- Buchwald H, Varco RL, Matts JP, et al. Effect of partial ileal bypass surgery on mortality and morbidity from coronary heart disease in patients with hypercholesterolemia: report of the Program on the Surgical Control of the Hyperlipidemias (POSCH). N Engl J Med 1990;323(l4):946–55
- Report of the National Cholesterol Education Program Expert Panel on Detecrion, Evaluation, and Treatment of High Blood Cholesterol in Adults: the Expert Panel. Arch Intern Med 1988;148(l):36–69
- LaRosa JC, Cleeman JI. Cholesterol lowering as a treatment for established coronary heart disease. Circulation 1992;85(3):1229–35